Sign in
4

Changes in Ownership

GT Biopharma, Inc. Filed Acc 0001181431-03-027473

Options or other derivatives

  • Director acquired 30,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
WEBB TED FORD Director 2003-09-30 Grant or award · Stock Option (right to buy) −30,000 $0.38 $11,400 30,000 D: show line 1 in the form
Loading xslF345X02/rrd20897.xml…